Quality Controls QC Data Management Resources Support Login Home Quality Controls COVID-19 Peer reportsMy eInsertsEQAS COVID-19 Quality Controls Solutions We’ll solve it. Together. Features SARS-CoV-2 controls Resources Request product info Bio-Rad has partnered with countless healthcare professionals, diagnostic laboratories, and researchers to help end the COVID-19 global pandemic. We offer both molecular and serology controls for monitoring your SARS-CoV-2 testing assay. The SARS-CoV-2, Flu, RSV Run Controls allow laboratories to evaluate day-to-day and lot-to-lot variation of their multiplexed molecular assay and to test for operator proficiency. Our serology controls are optimized for major total and IgG antibody and assay methodologies. Precise, reliable COVID-19 testing Optimized for major platforms, wider scope Multiple gene targets, increased reliability High-quality controls, reduced troubleshooting COVID-19 quality controls New Exact Diagnostics SARS-CoV-2 S Gene Variant Controls Product details Features Quantitated with ddPCR Synthetic matrix, including human genomic DNA (gDNA) 0.25 mL, 4 variant options Alpha, Beta, Delta-Kappa, Epsilon and Gamma variants Open-vial stability 7 days (2°C to 8°C) Shelf life 18 months (-20°C) or 12 months (2°C to 8°C) SARS-CoV-2  COVID-19 New VIROTROL SARS-CoV-2 (IVD/CE Mark) Product details Features Unassayed, reactive control Human plasma–based 4 mL—single level SARS-CoV-2 total IgG/IgM, SARS-CoV-2 IgG Open-vial stability 60 days (2°C to 8°C) Shelf life 24 months (2°C to 8°C) Serology SARS-CoV-2  COVID-19 New VIROCLEAR SARS-CoV-2 (IVD/CE Mark) Product details Features Unassayed, non-reactive control Human plasma–based 4 mL—single level SARS-CoV-2 total IgG/IgM, SARS-CoV-2 IgG Open-vial stability 60 days (2°C to 8°C) Shelf life 24 months (2°C to 8°C) Serology SARS-CoV-2  Negative New Exact Diagnostics SARS-CoV-2, Flu, RSV Run Controls Product details Features Calibrated with ddPCR Synthetic matrix, including human genomic DNA (gDNA) 1.0 mL—standard, negative Whole organism SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus (RSV) (A) Shelf life 24 months (from date of manufacture) Molecular SARS-CoV-2 COVID-19 New Exact Diagnostics SARS-CoV-2 Standard Product details Features Quantitated with ddPCR Synthetic matrix, including human genomic DNA (gDNA) 0.3 mL—five gene targets E, N, ORF1ab, ... Open-vial stability 24 hours (2°C to 8°C) Shelf life 18 months (from date of manufacture) Molecular SARS-CoV-2 COVID-19 New SARS-CoV-2 Negative Product details Features Negative for SARS-CoV-2 Formulated in a synthetic matrix Genomic DNA at 75,000 copies/mL 0.3 mL Open-vial stability 24 hours (2°C to 8°C) Shelf life 18 months (from date of manufacture) Molecular Negative SARS-CoV-2 Exact Diagnostics Respiratory Positive - Negative Run Controls Product details Features Manufacturing targets established using ddPCR Synthetic matrix Six vials of 0.3 mL each—positive, negative 23 respiratory analytes (combination of whole inactivated organisms and synthetic RNA transcripts) Open-vial stability Once thawed, positive control must be used immediately Shelf life 18 months (from date of manufacture) SARS-CoV-2 Multi-analyte Resources SARS-CoV-2 QC for molecular and serology assays Webinar On Demand Verifying commercial FDA-approved COVID tests Article Comparison of four molecular IVD assays to detect SARS-CoV-2 Article Request product information Email First Name Last Name Institution What products are you interested in? SARS-CoV-2, Flu, RSV Positive Run Control SARS-CoV-2, Flu, RSV Negative Run Control SARS-CoV-2 Standard SARS-CoV-2 Negative SARS-CoV-2 Positive Run Control SARS-CoV-2 Negative Run Control VIROTROL SARS-CoV-2 (IVD/CE Mark) VIROCLEAR SARS-CoV-2 (IVD/CE Mark) Country/Region Select Country USA Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central Africa Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo (Democratic Republic of the) Costa Rica Croatia Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Federated States of Micronesia Fiji Islands Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macedonia (FYR) Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Moldova (Republic of) Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Northern Ireland Norway Oman Pakistan Palau Palestinian Territory (Occupied) Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Barthelemy Saint Kitts and Nevis Saint Vincent and the Grenadines Samoa Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea South Sudan Spain Sri Lanka Saint Lucia Sudan Suriname Swaziland Sweden Switzerland Syria Tahiti Taiwan Tajikistan Tanzania Thailand The Netherlands Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (U.S.) Western Sahara Yemen Zaire Zambia Zimbabwe Submit Your Privacy Matters Before you visit, we want to let you know we use cookies to offer you a better browsing experience. To learn more about how we use cookies, please review our Cookie Policy, accessible from the Manage Preferences link below. We would appreciate your confirmation by either accepting all cookies or by declining and managing your cookie preferences under the Manage Preferences link below. Accept & Continue Decline Cookies Manage Cookie Preferences Quality Controls Blood Gas Cardiac Markers Chemistry Serum Indices Coagulation COVID-19 Diabetes Hematology Immunoassay Immunology Infectious Disease Molecular Controls Serology Controls InteliQ Load & Go Therapeutic Drug Toxicology Tumor Markers Urinalysis Data Management EQAS EQAS Online & Reports EQAS Steering Committee Members Linearty Web Mission: Control Peer Reporting Program Peer Reports Login QC Data Submission Calendar Unity QC Software Solutions Unity Real Time Online UnityWeb Resources Barcode Label Generator Critical Raw Materials Frequently Asked Questions Technical Documents eInserts eInsert XML Files Unity/EQAS Bulletin Training & Education QC Training & Education QC Data Management Training & Education EQAS Training & Education Value Assignment Program Support About Us Contact Us My Account / Lab Admin Press Releases Privacy Policy QCNet International Terms of Use Manage Cookie Preferences Copyright 2021 Bio-Rad Laboratories, Inc. All rights reserved. United States